Found: 95
Select item for more details and to access through your institution.
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program.
- Published in:
- Diabetologia, 2019, v. 62, n. 6, p. 926, doi. 10.1007/s00125-019-4839-8
- By:
- Publication type:
- Article
Feasibility of Serial 6-minWalk Tests in Patients with Acute Heart Failure.
- Published in:
- Journal of Clinical Medicine, 2017, v. 6, n. 9, p. 84, doi. 10.3390/jcm6090084
- By:
- Publication type:
- Article
World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial.
- Published in:
- Vascular Medicine, 2022, v. 27, n. 1, p. 21, doi. 10.1177/1358863X211038620
- By:
- Publication type:
- Article
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y<sub>12</sub> inhibitors: Insights from the EUCLID trial.
- Published in:
- Vascular Medicine, 2021, v. 26, n. 6, p. 608, doi. 10.1177/1358863X211017641
- By:
- Publication type:
- Article
From the Masters: A sea-change for TransAtlantic Inter-Society Consensus (TASC).
- Published in:
- Vascular Medicine, 2020, v. 25, n. 2, p. 103, doi. 10.1177/1358863X20905651
- By:
- Publication type:
- Article
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
- Published in:
- Vascular Medicine, 2019, v. 24, n. 5, p. 422, doi. 10.1177/1358863X19864172
- By:
- Publication type:
- Article
Lost in translation: Why 'lost to follow-up' matters.
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution.
- Published in:
- Vascular Medicine, 2018, v. 23, n. 6, p. 513, doi. 10.1177/1358863X18760996
- By:
- Publication type:
- Article
Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
- Published in:
- Vascular Medicine, 2018, v. 23, n. 6, p. 523, doi. 10.1177/1358863X18775594
- By:
- Publication type:
- Article
Prognostic value of an increase in post-exercise ankle-brachial index.
- Published in:
- Vascular Medicine, 2017, v. 22, n. 3, p. 204, doi. 10.1177/1358863X16676902
- By:
- Publication type:
- Article
An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
- Published in:
- Vascular Medicine, 2015, v. 20, n. 5, p. 465, doi. 10.1177/1358863X15597877
- By:
- Publication type:
- Article
Community-based walking exercise for peripheral artery disease: An exploratory pilot study.
- Published in:
- Vascular Medicine, 2015, v. 20, n. 4, p. 339, doi. 10.1177/1358863X15572725
- By:
- Publication type:
- Article
The Society for Vascular Medicine: The first quarter century.
- Published in:
- Vascular Medicine, 2015, v. 20, n. 1, p. 60, doi. 10.1177/1358863X14566042
- By:
- Publication type:
- Article
Short-term treatment with a novel HIF-prolyl hydroxylase inhibitor (GSK1278863) failed to improve measures of performance in subjects with claudication-limited peripheral artery disease.
- Published in:
- Vascular Medicine, 2014, v. 19, n. 6, p. 473, doi. 10.1177/1358863X14557151
- By:
- Publication type:
- Article
Effect of tirasemtiv, a selective activator of the fast skeletal muscle troponin complex, in patients with peripheral artery disease.
- Published in:
- Vascular Medicine, 2014, v. 19, n. 4, p. 297, doi. 10.1177/1358863X14534516
- By:
- Publication type:
- Article
Sodium nitrite in patients with peripheral artery disease and diabetes mellitus: Safety, walking distance and endothelial function.
- Published in:
- Vascular Medicine, 2014, v. 19, n. 1, p. 9, doi. 10.1177/1358863X13515043
- By:
- Publication type:
- Article
A systematic review and meta-analysis of propionyl-l-carnitine effects on exercise performance in patients with claudication.
- Published in:
- Vascular Medicine, 2013, v. 18, n. 1, p. 3, doi. 10.1177/1358863X12467491
- By:
- Publication type:
- Article
A validated biomarker panel to identify peripheral artery disease.
- Published in:
- Vascular Medicine, 2012, v. 17, n. 6, p. 386, doi. 10.1177/1358863X12463491
- By:
- Publication type:
- Article
l-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: A multicenter, randomized, double-blind, placebo-controlled trial.
- Published in:
- Vascular Medicine, 2012, v. 17, n. 3, p. 145, doi. 10.1177/1358863X12442264
- By:
- Publication type:
- Article
Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training.
- Published in:
- Vascular Medicine, 2012, v. 17, n. 2, p. 94, doi. 10.1177/1358863X11436334
- By:
- Publication type:
- Article
Progression of asymptomatic peripheral artery disease over 1 year.
- Published in:
- Vascular Medicine, 2012, v. 17, n. 1, p. 10, doi. 10.1177/1358863X11431106
- By:
- Publication type:
- Article
Chinese translation and validation of the Walking Impairment Questionnaire in patients with peripheral artery disease.
- Published in:
- Vascular Medicine, 2011, v. 16, n. 3, p. 167, doi. 10.1177/1358863X11404934
- By:
- Publication type:
- Article
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication.
- Published in:
- Vascular Medicine, 2010, v. 15, n. 3, p. 181, doi. 10.1177/1358863X10361545
- By:
- Publication type:
- Article
Effect of niacin ER/lovastatin on claudication symptoms in patients with peripheral artery disease.
- Published in:
- Vascular Medicine, 2010, v. 15, n. 3, p. 171, doi. 10.1177/1358863X09360579
- By:
- Publication type:
- Article
Measurement characteristics of the ankle--brachial index: results from the Action for Health in Diabetes study.
- Published in:
- Vascular Medicine, 2008, v. 13, n. 3, p. 225, doi. 10.1177/1358863X08091338
- By:
- Publication type:
- Article
A randomized trial of iloprost in patients with intermittent claudication.
- Published in:
- Vascular Medicine, 2008, v. 13, n. 1, p. 5, doi. 10.1177/1358863X07084910
- By:
- Publication type:
- Article
The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.
- Published in:
- Vascular Medicine, 2008, v. 13, n. 1, p. 15, doi. 10.1177/1358863X07084911
- By:
- Publication type:
- Article
Risk assessment in the patient with established peripheral arterial disease.
- Published in:
- Vascular Medicine, 2007, v. 12, n. 4, p. 343, doi. 10.1177/1358863X07083278
- By:
- Publication type:
- Article
Why TASC II?
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease.
- Published in:
- Vascular Medicine, 2007, v. 12, n. 4, p. 285, doi. 10.1177/1358863X07084858
- By:
- Publication type:
- Article
Editorial.
- Published in:
- Vascular Medicine, 2006, v. 11, n. 4, p. 258, doi. 10.1177/1358863x06072212
- By:
- Publication type:
- Article
Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies.
- Published in:
- Vascular Medicine, 2006, v. 11, n. 3, p. 141, doi. 10.1177/1358863x06069513
- By:
- Publication type:
- Article
Antiplatelet therapy for peripheral arterial disease and claudication.
- Published in:
- Vascular Medicine, 2006, v. 11, n. 1, p. 55, doi. 10.1191/1358863x06vm653xx
- By:
- Publication type:
- Article
Quality of the assessment of primary and secondary endpoints in claudication and critical leg ischemia trials.
- Published in:
- Vascular Medicine, 2005, v. 10, n. 3, p. 207, doi. 10.1191/1358863x05vm628oa
- By:
- Publication type:
- Article
Utility and barriers to performance of the ankle – brachial index in primary care practice.
- Published in:
- Vascular Medicine, 2004, v. 9, n. 4, p. 253, doi. 10.1191/1358863x04vm559oa
- By:
- Publication type:
- Article
The effect of inhibition of acyl coenzyme A-cholesterol acyltransferase (ACAT) on exercise performance in patients with peripheral arterial disease.
- Published in:
- Vascular Medicine, 2004, v. 9, n. 4, p. 271, doi. 10.1191/1358863x04vm569oa
- By:
- Publication type:
- Article
Skeletal muscle metabolic changes in peripheral arterial disease contribute to exercise intolerance: a point — counterpoint discussion.
- Published in:
- Vascular Medicine, 2004, v. 9, n. 4, p. 293, doi. 10.1191/1358863x04vm572ra
- By:
- Publication type:
- Article
Randomized trial of AT-1015 for treatment of intermittent claudication. A novel 5-hydroxytryptamine antagonist with no evidence of efficacy.
- Published in:
- Vascular Medicine, 2004, v. 9, n. 1, p. 18, doi. 10.1191/1358863x04vm520oa
- By:
- Publication type:
- Article
Proteinuria in a placebo-controlled study of basic fibroblast growth for intermittent claudication.
- Published in:
- Vascular Medicine, 2001, v. 6, n. 4, p. 235, doi. 10.1177/1358836X0100600406
- By:
- Publication type:
- Article
PAD awareness, risk, and treatment: new resources for survival - the USA PARTNERS program.
- Published in:
- Vascular Medicine, 2001, v. 6, n. 1S, p. 9, doi. 10.1177/1358836X0100600i103
- By:
- Publication type:
- Article
Exercise in the treatment of intermittent claudication due to peripheral arterial disease.
- Published in:
- Vascular Medicine, 1991, v. 2, n. 1, p. 61, doi. 10.1177/1358836X9100200106
- By:
- Publication type:
- Article
Short-Term Effects of Estrogen and Progestin on Blood Pressure of Normotensive Postmenopausal Women.
- Published in:
- 1991
- By:
- Publication type:
- Other
Risk assessment in drug development for symptomatic indications: A framework for the prospective exclusion of unacceptable cardiovascular risk.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 3, p. 165, doi. 10.1016/j.clpt.2005.11.012
- By:
- Publication type:
- Article
Effect of intravenous L-carnitine on carnitine homeostasis and fuel metabolism during exercise in humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 1994, v. 55, n. 6, p. 681, doi. 10.1038/clpt.1994.85
- By:
- Publication type:
- Article
Abciximab added to urokinase increased amputation-free survival in peripheral arterial occlusion of the legs.
- Published in:
- ACP Journal Club, 2002, v. 137, n. 1, p. 12, doi. 10.7326/acpjc-2002-137-1-012
- By:
- Publication type:
- Article
Carnitine and Peripheral Arterial Disease.
- Published in:
- Annals of the New York Academy of Sciences, 2004, v. 1033, n. 1, p. 92, doi. 10.1196/annals.1320.008
- By:
- Publication type:
- Article
Cardiovascular Risk Assessment in the Development of New Drugs for Obesity.
- Published in:
- 2012
- By:
- Publication type:
- Proceeding
Aspirin for Prevention of Stroke and Cardiovascular Events Among Patients With Peripheral Artery Disease.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 301, n. 18, p. 1909, doi. 10.1001/jama.2009.623
- By:
- Publication type:
- Article